Oxford vaccine trial pause isn’t bad news – it’s the process working

By Clare Wilson

Michelle D’Urbano

The has been tall terror over the news that a trial of a vaccine candidate for the coronavirus, from the College of Oxford and drug firm AstraZeneca, has needed to be placed on elevate after a participant developed queer neurological indicators.

It may maybe possibly maybe well appear a trigger for venture, but, if truth be told, it shows that study and pattern for this vaccine is proceeding exactly because it would possibly most likely possibly maybe well attain. It moreover highlights the likelihood of bypassing the well-liked stage of mountainous security trials, as Russia and China appear to be doing with their vaccines.

We don’t but know the …